Unicycive Therapeutics Stock Price To Earnings To Growth

UNCY Stock  USD 0.71  0.03  4.05%   
Unicycive Therapeutics fundamentals help investors to digest information that contributes to Unicycive Therapeutics' financial success or failures. It also enables traders to predict the movement of Unicycive Stock. The fundamental analysis module provides a way to measure Unicycive Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Unicycive Therapeutics stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Unicycive Therapeutics Company Price To Earnings To Growth Analysis

Unicycive Therapeutics' PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.

Unicycive Price To Earnings To Growth Driver Correlations

Understanding the fundamental principles of building solid financial models for Unicycive Therapeutics is extremely important. It helps to project a fair market value of Unicycive Stock properly, considering its historical fundamentals such as Price To Earnings To Growth. Since Unicycive Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Unicycive Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Unicycive Therapeutics' interrelated accounts and indicators.
-0.910.930.88-0.30.830.25-0.810.770.19-0.510.820.23-0.24-0.680.68
-0.91-0.81-0.750.18-0.660.150.62-0.950.20.38-0.90.170.10.85-0.88
0.93-0.810.78-0.490.790.29-0.710.630.24-0.380.80.26-0.15-0.460.58
0.88-0.750.78-0.260.970.5-0.980.710.45-0.410.740.48-0.17-0.640.63
-0.30.18-0.49-0.26-0.24-0.280.21-0.07-0.33-0.32-0.04-0.27-0.450.050.11
0.83-0.660.790.97-0.240.59-0.970.590.55-0.40.760.57-0.19-0.450.59
0.250.150.290.5-0.280.59-0.64-0.260.99-0.23-0.041.0-0.220.28-0.29
-0.810.62-0.71-0.980.21-0.97-0.64-0.56-0.590.48-0.65-0.620.270.5-0.52
0.77-0.950.630.71-0.070.59-0.26-0.56-0.31-0.280.85-0.29-0.01-0.940.94
0.190.20.240.45-0.330.550.99-0.59-0.31-0.11-0.090.99-0.10.33-0.34
-0.510.38-0.38-0.41-0.32-0.4-0.230.48-0.28-0.11-0.35-0.220.950.3-0.3
0.82-0.90.80.74-0.040.76-0.04-0.650.85-0.09-0.35-0.06-0.14-0.640.93
0.230.170.260.48-0.270.571.0-0.62-0.290.99-0.22-0.06-0.210.3-0.31
-0.240.1-0.15-0.17-0.45-0.19-0.220.27-0.01-0.10.95-0.14-0.210.03-0.1
-0.680.85-0.46-0.640.05-0.450.280.5-0.940.330.3-0.640.30.03-0.8
0.68-0.880.580.630.110.59-0.29-0.520.94-0.34-0.30.93-0.31-0.1-0.8
Click cells to compare fundamentals
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Competition

Unicycive Price Earnings To Growth Ratio

Price Earnings To Growth Ratio

(0.0993)

At this time, Unicycive Therapeutics' Price Earnings To Growth Ratio is fairly stable compared to the past year.
Based on the latest financial disclosure, Unicycive Therapeutics has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.

Did you try this?

Run Idea Optimizer Now

   

Idea Optimizer

Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
All  Next Launch Module

Unicycive Fundamentals

About Unicycive Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Unicycive Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Unicycive Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Unicycive Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Unicycive Stock Analysis

When running Unicycive Therapeutics' price analysis, check to measure Unicycive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unicycive Therapeutics is operating at the current time. Most of Unicycive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Unicycive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Unicycive Therapeutics' price. Additionally, you may evaluate how the addition of Unicycive Therapeutics to your portfolios can decrease your overall portfolio volatility.